Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Sponsor: Neurocrine Biosciences
Summary
The primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in pediatric and adult participants who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.
Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Key Details
Gender
All
Age Range
6 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2022-04-15
Completion Date
2026-06
Last Updated
2025-08-01
Healthy Volunteers
No
Conditions
Interventions
Placebo
Capsule, administered once daily orally or via gastrostomy/gastrojejunostomy tube
Valbenazine
Capsule, administered once daily orally or via gastrostomy/gastrojejunostomy tube
Locations (38)
Neurocrine Clinical Site
San Diego, California, United States
Neurocrine Clinical Site
Aurora, Colorado, United States
Neurocrine Clinical Site
Stamford, Connecticut, United States
Neurocrine Clinical Site
Gulf Breeze, Florida, United States
Neurocrine Clinical Site
Miami, Florida, United States
Neurocrine Clinical Site
Orlando, Florida, United States
Neurocrine Clinical Site
Chicago, Illinois, United States
Neurocrine Clinical Site
Baltimore, Maryland, United States
Neurocrine Clinical Site
Boston, Massachusetts, United States
Neurocrine Clinical Site
Farmington Hills, Michigan, United States
Neurocrine Clinical Site
Saint Paul, Minnesota, United States
Neurocrine Clinical Site
New York, New York, United States
Neurocrine Clinical Site
Cincinnati, Ohio, United States
Neurocrine Clinical Site
Columbus, Ohio, United States
Neurocrine Clinical Site
Oklahoma City, Oklahoma, United States
Neurocrine Clinical Site
Portland, Oregon, United States
Neurocrine Clinical Site
Dallas, Texas, United States
Neurocrine Clinical Site
Fort Worth, Texas, United States
Neurocrine Clinical Site
Houston, Texas, United States
Neurocrine Clinical Site
Buenos Aires, Argentina
Neurocrine Clinical Site
Buenos Aires, Argentina
Neurocrine Clinical Site
Brussels, Belgium
Neurocrine Clinical Site
Brasília, Brazil
Neurocrine Clinical Site
Curitiba, Brazil
Neurocrine Clinical Site
Porto Alegre, Brazil
Neurocrine Clinical Site
Porto Alegre, Brazil
Neurocrine Clinical Site
Ẕerifin, Israel
Neurocrine Clinical Site
Calambrone, Italy
Neurocrine Clinical Site
Milan, Italy
Neurocrine Clinical Site
Aguascalientes, Mexico
Neurocrine Clinical Site
Gdansk, Poland
Neurocrine Clinical Site
Krakow, Poland
Neurocrine Clinical Site
Oświęcim, Poland
Neurocrine Clinical Site
Lisbon, Portugal
Neurocrine Clinical Site
Lisbon, Portugal
Neurocrine Clinical Site
Porto, Portugal
Neurocrine Clinical Site
Barcelona, Spain
Neurocrine Clinical Site
Madrid, Spain